Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.780
-0.070 (-3.78%)
Oct 9, 2026, 4:00 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Cardiol Therapeutics the 38,683rd largest employer in the world and 698th in Canada.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-1.89M CAD
Market Cap
207.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cresco Labs | 2,900 |
| Ascend Wellness Holdings | 2,200 |
| Organigram Global | 1,120 |
| TerrAscend | 1,038 |
| Cannara Biotech | 452 |
| Auxly Cannabis Group | 446 |
| Medexus Pharmaceuticals | 90 |
| HLS Therapeutics | 85 |
Cardiol Therapeutics News
- 11 days ago - Tejara Capital Ltd Expands Stake in Cardiol Therapeutics Inc (CRDL) with 1.27 Million Share Purchase - GuruFocus
- 17 days ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 17 days ago - Cardiol Therapeutics (CRDL) Advances MAVERIC Phase III Trial, Market Implies High Growth ... - GuruFocus
- 17 days ago - Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial - TheFly
- 17 days ago - Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PRNewsWire
- 24 days ago - Cardiol Therapeutics (CRDL) Raises $7M via Warrants, Extends Runway into 2028 - GuruFocus
- 24 days ago - Cardiol Therapeutics Registration statement: Registration filing - Filings
- 24 days ago - Cardiol Therapeutics receives over $7M in proceeds from warrant exercise - TheFly